A Diversified Library of Bacterial and Fungal Bifunctional Cytochrome P450 Enzymes for Drug Metabolite Synthesis

• Published in: Advanced synthesis & catalysis Vol. 351; no. 13; pp. 2140 - 2146
• Main Authors: Weis, Roland, Winkler, Margit, Schittmayer, Matthias, Kambourakis, Spiros, Vink, Mandy, Rozzell, J. David, Glieder, Anton
• Format: Journal Article
• Language: English
• Published: Weinheim WILEY‐VCH Verlag 01.09.2009
• Subjects: active pharmaceutical ingredients (APIs); Aspergillus fumigatus; cytochrome P450 (CYP); Escherichia coli; hydroxylation; metabolites; mutagenesis
• ISSN: 1615-4150; 1615-4169
• DOI: 10.1002/adsc.200900190

Innovative biohydroxylation catalysts for the preparation of drug metabolites were developed from scratch. A set of bacterial and fungal sequences of putative and already known bifunctional P450 enzymes was identified by protein sequence alignments, expressed in Escherichia coli and characterised. Notably, a fungal self‐sufficient cytochrome P450 (CYP) from Aspergillus fumigatus turned out to be especially stable during catalyst preparation and application and also in presence of organic co‐solvents. To enhance the catalytic activity and broaden the substrate specificity of those variants with high expression levels prominent single mutations were introduced. Selected improved variants were then used as lyophilised bacterial lysates for the synthesis of 4′‐hydroxydiclofenac and 6‐hydroxychlorzoxazone, the two metabolites of active pharmaceutical compounds diclofenac and chlorzoxazone representing the same metabolites as generated by human P450s.